Literature DB >> 19903741

Positive regulation of spondin 2 by thyroid hormone is associated with cell migration and invasion.

Chen-Hsin Liao1, Shih-Chi Yeh, Ya-Hui Huang, Ruey-Nan Chen, Ming-Ming Tsai, Wei-Jan Chen, Hsiang-Cheng Chi, Pei-Ju Tai, Chia-Jung Liao, Sheng-Ming Wu, Wan-Li Cheng, Li-Mei Pai, Kwang-Huei Lin.   

Abstract

The thyroid hormone 3,3',5-triiodo-L-thyronine (T(3)) regulates growth, development, and differentiation processes in animals. These activities are mediated by the nuclear thyroid hormone receptors (TRs). Microarray analyses were performed previously to study the mechanism of regulation triggered by T(3) treatment in hepatoma cell lines. The results showed that spondin 2 was regulated positively by T(3). However, the underlying mechanism and the physiological role of T(3) in the regulation of spondin 2 are not clear. To verify the microarray results, spondin 2 was further investigated using semi-quantitative reverse transcription-PCR and western blotting. After 48 h of T(3) treatment in the HepG2-TR alpha 1#1 cell line, spondin 2 mRNA and protein levels increased by 3.9- to 5.7-fold. Similar results were observed in thyroidectomized rats. To localize the regulatory region in spondin 2, we performed serial deletions of the promoter and chromatin immunoprecipitation assays. The T(3) response element on the spondin 2 promoter was localized in the -1104/-1034 or -984/-925 regions. To explore the effect of spondin 2 on cellular function, spondin 2 knockdown cell lines were established from Huh7 cells. Knockdown cells had higher migration ability and invasiveness compared with control cells. Conversely, spondin 2 overexpression in J7 cells led to lower migration ability and invasiveness compared with control cells. Furthermore, this study demonstrated that spondin 2 overexpression in some types of hepatocellular carcinomas is TR dependent. Together, these experimental findings suggest that spondin 2, which is regulated by T(3), has an important role in cell invasion, cell migration, and tumor progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19903741     DOI: 10.1677/ERC-09-0050

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  21 in total

1.  Identification of differentially regulated secretome components during skeletal myogenesis.

Authors:  C Y X'avia Chan; Olena Masui; Olga Krakovska; Vladimir E Belozerov; Sebastien Voisin; Shaun Ghanny; Jian Chen; Dharsee Moyez; Peihong Zhu; Kenneth R Evans; John C McDermott; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2011-02-22       Impact factor: 5.911

2.  Intrinsic disorder in spondins and some of their interacting partners.

Authors:  Oluwole Alowolodu; Gbemisola Johnson; Lamis Alashwal; Iqbal Addou; Irina V Zhdanova; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-12-15

3.  Stable isotope labeling with amino acids in cell culture (SILAC)-based quantitative proteomics study of a thyroid hormone-regulated secretome in human hepatoma cells.

Authors:  Cheng-Yi Chen; Lang-Ming Chi; Hsiang-Cheng Chi; Ming-Ming Tsai; Chung-Ying Tsai; Yi-Hsin Tseng; Yang-Hsiang Lin; Wei-Jan Chen; Ya-Hui Huang; Kwang-Huei Lin
Journal:  Mol Cell Proteomics       Date:  2011-12-14       Impact factor: 5.911

Review 4.  The Clinical Relevance of Hypothyroidism in Patients with Solid Non-Thyroid Cancer: A Tantalizing Conundrum.

Authors:  Maria V Deligiorgi; Dimitrios T Trafalis
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

5.  Chromosome 19 open reading frame 80 is upregulated by thyroid hormone and modulates autophagy and lipid metabolism.

Authors:  Yi-Hsin Tseng; Po-Yuan Ke; Chia-Jung Liao; Sheng-Ming Wu; Hsiang-Cheng Chi; Chung-Ying Tsai; Cheng-Yi Chen; Yang-Hsiang Lin; Kwang-Huei Lin
Journal:  Autophagy       Date:  2013-11-11       Impact factor: 16.016

6.  The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.

Authors:  L-F Wang; Y-S Liu; B Yang; P Li; X-S Cheng; C-X Xiao; J-J Liu; S Li; J-L Ren; B Guleng
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

Review 7.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

8.  Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.

Authors:  I-Hsiao Chung; Cheng-Yi Chen; Yang-Hsiang Lin; Hsiang-Cheng Chi; Ya-Hui Huang; Pei-Ju Tai; Chia-Jung Liao; Chung-Ying Tsai; Syuan-Ling Lin; Meng-Han Wu; Ching-Ying Chen; Kwang-Huei Lin
Journal:  Oncotarget       Date:  2015-06-20

9.  Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.

Authors:  Qian Zhang; Xiao-Qing Wang; Jie Wang; Shu-Jian Cui; Xiao-Min Lou; Bing Yan; Jie Qiao; Ying-Hua Jiang; Li-Jun Zhang; Peng-Yuan Yang; Feng Liu
Journal:  Oncotarget       Date:  2015-06-20

Review 10.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.